Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Thyroid : Official Journal of the American Thyroid Association
|
October 20, 2012
Functional analysis of the murine Pax8 promoter reveals autoregulation and the presence of a novel thyroid-specific DNA-binding activity
Alessandra di Gennaro, Olga Spadaro, Maria Giuseppina Baratta, et al.
Molecular Endocrinology (Baltimore, Md.)
|
April 15, 2006
Functional inactivation of the transcription factor Pax8 through oligomerization chain reaction
Barbara D'Andrea, Roberto Iacone, Tina Di Palma, et al.
Molecular Endocrinology (Baltimore, Md.)
|
September 25, 2004
Dose-dependent inhibition of thyroid differentiation by RAS oncogenes
Gabriella De Vita, Lisa Bauer, Vania M Correa da Costa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 24, 2014
An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma
Maria Giuseppina Baratta, Anna C Schinzel, Yaara Zwang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Thyroid : Official Journal of the American Thyroid Association
|
October 20, 2012
Functional analysis of the murine Pax8 promoter reveals autoregulation and the presence of a novel thyroid-specific DNA-binding activity
Alessandra di Gennaro, Olga Spadaro, Maria Giuseppina Baratta, et al.
Molecular Endocrinology (Baltimore, Md.)
|
April 15, 2006
Functional inactivation of the transcription factor Pax8 through oligomerization chain reaction
Barbara D'Andrea, Roberto Iacone, Tina Di Palma, et al.
Molecular Endocrinology (Baltimore, Md.)
|
September 25, 2004
Dose-dependent inhibition of thyroid differentiation by RAS oncogenes
Gabriella De Vita, Lisa Bauer, Vania M Correa da Costa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 24, 2014
An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma
Maria Giuseppina Baratta, Anna C Schinzel, Yaara Zwang, et al.
Page
of 2